Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07491367
PHASE4

Pilot Exploration of Platelet Characterization of Platelet Rich Plasma Created by Two Different Systems

Sponsor: University of California, San Francisco

View on ClinicalTrials.gov

Summary

The investigators would like to study the differences in the quality of Platelet Rich Plasma (PRP) between two different machines in those with knee osteoarthritis. Knee osteoarthritis means your cartilage has been worn down, and it affects your knee joint. Both machines, the APEX Biologix XCELL PRP System and the Emcyte PurePRP Supraphysiologic Concentrating System, are FDA approved, commercially available, and makes PRP. The investigators will check if the platelets in the PRP have different amounts or work differently. The investigators will also assess participants symptoms after the injection and compare the two different preparation systems.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-03

Completion Date

2028-09

Last Updated

2026-03-24

Healthy Volunteers

No

Interventions

BIOLOGICAL

Platelet Rich Plasma

The Platelet Rich Plasma (PRP) participants will receive in this study will be made by Emcyte PurePRP Supraphysiologic Concentrating System or the APEX Biologix XCELL PRP System.

DEVICE

Emcyte PurePRP Supraphysiologic Concentrating System

Platelet Rich Plasma (PRP) will be made by the Emcyte PurePRP Supraphysiologic Concentrating System.

DEVICE

APEX Biologix XCELL PRP System

Platelet Rich Plasma (PRP) will be made by APEX Biologix XCELL PRP System.

Locations (1)

University of California San Francisco

San Francisco, California, United States